# High‐dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited‐stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

**Authors:** Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets, Luigi Marcheselli, Caterina Cristinelli, Barbara Botto, Sanne Tonino, Doriane Cavalieri, Alessandro Pulsoni, Martin Hutchings, Mohammad Hammoud, Catherine Fortpied, Luigi Rigacci, Wouter Plattel, Marc André, Massimo Federico

PMC · DOI: 10.1002/hem3.70105 · HemaSphere · 2025-04-02

## Full-text entities

- **Diseases:** Hodgkin lymphoma (MESH:D006689)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11962756/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11962756/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11962756/full.md

---
Source: https://tomesphere.com/paper/PMC11962756